Who
Pete O'Heeron
Chief Executive Officer
Company insider
Files Form 4 as: COB, Secretary, Treasurer, Liberty Star Uranium & Metals; Chief Executive Officer, FibroBiologics.
In numbers
- Trades disclosed
- 63
- Buys
- 24
- Sells
- 0
- Bought
- $2.0M
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 5 Sep 2013
- Last trade
- 28 Sep 2026
- Last filed
- 30 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 Sep 2026filed 30 Sep 2026 | Liberty Star Uranium & Metalsoption or derivative | SEC FORM 4 Code P | $1,71585,741 at $0.02 | filing |
| 28 Sep 2026filed 30 Sep 2026 | Liberty Star Uranium & Metals | SEC FORM 4 Bought | $3,430171,482 at $0.02 | filing |
| 4 May 2026filed 4 May 2026 | FBLG FibroBiologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —92,410 at $0.00 | filing |
| 4 May 2026filed 4 May 2026 | FBLG FibroBiologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —92,410 at $0.00 | filing |
| 4 Mar 2026filed 4 Mar 2026 | FBLG FibroBiologicsBiotechnology | SEC FORM 4 Bought | $6,00615,872 at $0.3784 | filing |
| 4 Mar 2026filed 4 Mar 2026 | FBLG FibroBiologicsBiotechnology | SEC FORM 4 Bought | $6,03115,872 at $0.38 | filing |
| 3 Mar 2026filed 4 Mar 2026 | FBLG FibroBiologicsBiotechnology | SEC FORM 4 Bought | $7,37318,200 at $0.4051 | filing |
| 3 Mar 2026filed 4 Mar 2026 | FBLG FibroBiologicsBiotechnology | SEC FORM 4 Bought | $7,46218,200 at $0.41 | filing |
| 2 Mar 2026filed 4 Mar 2026 | FBLG FibroBiologicsBiotechnology | SEC FORM 4 Bought | $6,15217,428 at $0.353 | filing |
| 2 Mar 2026filed 4 Mar 2026 | FBLG FibroBiologicsBiotechnology | SEC FORM 4 Bought | $6,10017,428 at $0.35 | filing |
| 20 Aug 2025filed 22 Aug 2025 | Liberty Star Uranium & Metalsoption or derivative | SEC FORM 4 Code A | $70K1,000,000 at $0.07 | filing |
| 27 May 2025filed 27 May 2025 | Liberty Star Uranium & Metalsoption or derivative | SEC FORM 4 Code P | $112K1,595,359 at $0.07 | filing |
| 27 May 2025filed 27 May 2025 | Liberty Star Uranium & Metals | SEC FORM 4 Bought | $223K3,190,718 at $0.07 | filing |
| 26 Mar 2025filed 28 Mar 2025 | FBLG FibroBiologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —453,000 at $0.00 | filing |
| 4 Mar 2025filed 4 Mar 2025 | Liberty Star Uranium & Metalsoption or derivative | SEC FORM 4 Code P | $139K1,540,335 at $0.09 | filing |
| 4 Mar 2025filed 4 Mar 2025 | Liberty Star Uranium & Metals | SEC FORM 4 Bought | $277K3,080,670 at $0.09 | filing |
| 29 Jan 2025filed 31 Jan 2025 | Liberty Star Uranium & Metalsoption or derivative | SEC FORM 4 Code A | $70K583,333 at $0.12 | filing |
| 27 Dec 2024filed 30 Dec 2024 | FBLG FibroBiologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —406,339 at $0.00 | filing |
| 9 Dec 2024filed 9 Dec 2024 | FBLG FibroBiologicsBiotechnology | SEC FORM 4 Code G | —100,000 at $0.00 | filing |
| 3 Dec 2024filed 5 Dec 2024 | FBLG FibroBiologicsBiotechnology | SEC FORM 4 Code G | —50,000 at $0.00 | filing |
News
FibroBiologics Presents Preclinical Data on Fibroblast Spheroid-Derived Chondrocyte Spheroids for Degenerative Disc Disease at the North American Spine Society 2026 Annual Meeting – Ortho Spine NewsFBLG · orthospinenews.com · 19 Oct 2026
0 headlines in the last 90 days name Pete O'Heeron; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.